Compare HALO & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | PCOR |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 9.6B |
| IPO Year | 2001 | 2020 |
| Metric | HALO | PCOR |
|---|---|---|
| Price | $107.93 | $52.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 24 |
| Target Price | ★ $99.56 | $68.19 |
| AVG Volume (30 Days) | 2.0M | ★ 2.2M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.94 |
| EPS | ★ 3.11 | 0.05 |
| Revenue | $151,862,000.00 | ★ $1,322,509,000.00 |
| Revenue This Year | $32.72 | $14.50 |
| Revenue Next Year | $10.61 | $13.30 |
| P/E Ratio | ★ $36.16 | $993.80 |
| Revenue Growth | N/A | ★ 14.83 |
| 52 Week Low | $61.23 | $38.03 |
| 52 Week High | $116.85 | $82.32 |
| Indicator | HALO | PCOR |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 48.31 |
| Support Level | $104.49 | $45.91 |
| Resistance Level | $111.15 | $55.55 |
| Average True Range (ATR) | 3.04 | 2.08 |
| MACD | -0.71 | -0.06 |
| Stochastic Oscillator | 42.53 | 57.50 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.